Emerging Drug Treatments for Solid Tumours
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 51 (1) , 45-72
- https://doi.org/10.2165/00003495-199651010-00005
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Activity of docetaxel (Taxotere) in small cell lung cancerEuropean Journal Of Cancer, 1994
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Effects of taxotere on murine and human tumor cell linesBiochemical and Biophysical Research Communications, 1992
- IdarubicinDrugs, 1991
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapyPharmacology & Therapeutics, 1988
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983
- Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesisCell, 1981